All three Covid-19 vaccines available in America are remarkably effective. As the Centers for Disease Control and Prevention put it, “The best Covid-19 vaccine is the first one that is available to you.” Most people aren’t even in a position to choose which one they get. “It’s like the sorting hat in ‘Harry Potter,’” said Mr. Thomas.

You Pfizer, Me Moderna: Vaccine Recipients Declare Loyalty

In 91 days, we are 99.71% of the way to President Biden's goal of 200 million shots in 100 days. We can expect to formally meet this goal tomorrow. #VaccinateAmerica

@STWorg @ceptional

2/2 Over the next 10 days, we will pick out key themes for critical discussion to see what progress was achieved, what aspirations were dashed, and general discussion of what we can build on going forward

It is 13 months since the piece on "reconfiguring behavioural science" for crisis knowledge management that led to http://SciBeh.org What have we learned? What did the behavioural sciences get right? What went wrong? Join the discussion! 1/2

However, less has been mentioned about how vaccine passports may generate or compound inequalities; those who are unable to get a vaccine may be limited in their participation in public, social, and economic life. Currently, there are many groups who are unable to get a vaccine; those who can’t for health reasons; younger population groups, with most national vaccination campaigns basing distribution on age as the key predictor of risk; and anyone in a LMIC which do not have purchase agreements with pharmaceutical firms, or have only managed to procure enough for a small percentage of their population through the COVAX mechanism, and therefore will be many years before a widespread national rollout is possible. Requiring a vaccine passport will exclude these groups—and if history of public health has told us anything, excluding people based on their health status is dangerous, and ethically reprehensible. 

Clare Wenham: Why vaccine passports are gendered

Scientists and researchers managed to produce vaccines to protect against COVID-19. Vaccine candidates have recently been approved in some countries and are in the approval process in others, yet misinformation about the safety and effects of any future vaccine is already threatening its rollout. In this report, we catalogue the top myths about a COVID-19 vaccine that have appeared in NewsGuard’s ratings of more than 6,000 news and information sites worldwide.

The Top COVID-19 Vaccine Myths Spreading Online

Intense pressures on the already overstretched NHS are being exacerbated by the tens of thousands of health staff who are sick with long Covid, doctors and hospital bosses say.At least 122,000 NHS personnel have the condition, the Office for National Statistics disclosed in a detailed report that showed 1.1 million people in the UK were affected by the condition. That is more than any other occupational group and ahead of teachers, of whom 114,000 have it.

Strain on NHS as tens of thousands of staff suffer long Covid

Ontario is entering another lockdown, mere weeks after restrictions lifted. Undoubtedly, we opened too early. The number of COVID-19 patients admitted to hospital when we eased restrictions in February was 10 times what they were when we reopened in the summer.

Ontario’s COVID-19 failure stems from politicians’ inability to understand how people behave

Younger Brazilians Are Dying From Covid in an Alarming New Shift

So far this month, according to government data, about 2,030 Brazilians aged 30 to 39 have died from Covid, more than double the number recorded in January. Among those in their 40s, there have been 4,150 fatalities in March, up from 1,823 in January, and for those 20-29, deaths jumped to 505 from 242.

NEW BRUNSWICK, N.J., March 29, 2021 /PRNewswire/ -- Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) (the Company), has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate to African Union's 55 member states with delivery beginning in the third quarter of 2021. AVAT also has the potential to order an additional 180 million doses, for a combined total of up to 400 million doses through 2022. The availability of the vaccine candidate is subject to its successful approval or authorization by the national regulatory authorities of AU member states.

Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company's COVID-19 Vaccine Candidate